Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
80,613,065
-
Shares change
-
+78,221
-
Total reported value, excl. options
-
$41,878,151
-
Value change
-
+$4,656
-
Number of buys
-
6
-
Number of sells
-
5
-
Price
-
$0.5190
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2022
As of 30 Jun 2022 Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 80,613,065 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Altium Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Crescent Grove Advisors, LLC, Midwest Professional Planners, LTD., SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Tower Research Capital LLC (TRC).
This table shows 12 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.